Skip to content
FSEGA Investment Club
  • Home
  • Events
  • Market & Company News
  • About
  • Members
  • Contact
Linkedin Facebook

FSEGA Investment Club
  • Robust product mix and brand revenues support growth despite flat shipments for Ferrari in the second-quarter
    Market & Company News

    Robust product mix and brand revenues support growth despite flat shipments for Ferrari in the second-quarter

    ByInvestment Club August 5, 2025August 5, 2025

    Overview Ferrari delivered strong financial results in the second quarter of 2025, driven by an enriched product mix, higher personalizations, and strong brand performance, despite essentially flat shipments. “The first semester of 2025 reminded us once more about the importance of agility and flexibility in the management of our Company. Today’s strong results reflect our…

    Read More Robust product mix and brand revenues support growth despite flat shipments for Ferrari in the second-quarterContinue

  • Booking Holdings reports Q2 2025 results with strong travel demand and profit growth
    Market & Company News

    Booking Holdings reports Q2 2025 results with strong travel demand and profit growth

    ByInvestment Club August 5, 2025August 5, 2025

    Overview Booking Holdings delivered a strong second quarter of 2025, reflecting the ongoing recovery and growth in global travel demand. The company achieved double-digit revenue and profit growth, supported by robust room nights, expanding alternative accommodations, and continued momentum in flights and attractions. CEO Glenn Fogel highlighted: “I am pleased to report a strong quarter…

    Read More Booking Holdings reports Q2 2025 results with strong travel demand and profit growthContinue

  • Merck & Co reports Q2 2025 results with strong Oncology growth and strategic pipeline investments
    Market & Company News

    Merck & Co reports Q2 2025 results with strong Oncology growth and strategic pipeline investments

    ByInvestment Club August 5, 2025August 5, 2025

    Overview Merck & Co., Inc. delivered solid operational performance in Q2 2025 despite a slight decline in total revenue, reflecting robust oncology and cardiovascular growth offset by weaker vaccine sales. The company continued to advance its strategy with a focus on pipeline expansion and high-value acquisitions, including Verona Pharma, while initiating a multiyear optimization program…

    Read More Merck & Co reports Q2 2025 results with strong Oncology growth and strategic pipeline investmentsContinue

  • Price discipline and productivity initiatives offset lower volumes for Linde in Q2 2025
    Market & Company News

    Price discipline and productivity initiatives offset lower volumes for Linde in Q2 2025

    ByInvestment Club August 5, 2025August 5, 2025

    Overview Linde delivered another quarter of resilient performance in Q2 2025, driven by pricing actions, operational efficiency, and a focus on high-return projects. Despite softer volumes in certain industrial and manufacturing markets, the company achieved revenue growth, margin expansion, and robust cash generation. Management highlighted the continued execution of its high-quality project backlog and reaffirmed…

    Read More Price discipline and productivity initiatives offset lower volumes for Linde in Q2 2025Continue

  • U.S. commercial surge and AI adoption drive record growth for Palantir in the second-quarter
    Market & Company News

    U.S. commercial surge and AI adoption drive record growth for Palantir in the second-quarter

    ByInvestment Club August 4, 2025August 4, 2025

    Overview Palantir achieved a record-breaking Q2 2025, fueled by explosive growth in U.S. commercial operations and accelerating global adoption of its AI Platform (AIP). The company raised its full-year revenue guidance to +45% YoY, surpassing consensus expectations. CEO Alex Karp highlighted that the company’s U.S. commercial revenue nearly doubled, reflecting rapid enterprise adoption and deepening…

    Read More U.S. commercial surge and AI adoption drive record growth for Palantir in the second-quarterContinue

  • Record profitability driven by Bitcoin appreciation and capital markets expansion for Strategy in Q2 2025
    Market & Company News

    Record profitability driven by Bitcoin appreciation and capital markets expansion for Strategy in Q2 2025

    ByInvestment Club August 4, 2025August 4, 2025

    Overview Strategy (MicroStrategy) posted record Q2 2025 results, driven by the fair value appreciation of its substantial Bitcoin holdings and aggressive capital markets activity. Earnings reached historic highs, reflecting both Bitcoin price momentum and disciplined accretive capital deployment. CEO Phong Le highlighted the company’s leadership as the world’s first Bitcoin Treasury Company, with accelerating institutional…

    Read More Record profitability driven by Bitcoin appreciation and capital markets expansion for Strategy in Q2 2025Continue

  • “Back to Starbucks” strategy driving store growth amid margin pressure in the last quarter
    Market & Company News

    “Back to Starbucks” strategy driving store growth amid margin pressure in the last quarter

    ByInvestment Club August 4, 2025August 4, 2025

    Overview Starbucks posted Q3 FY2025 results showing modest revenue growth but significant margin contraction, reflecting ongoing investments in its “Back to Starbucks” strategy. EPS was negatively impacted by one-time investments in Leadership Experience 2025 and discrete tax adjustments. CEO Brian Niccol emphasized the progress in rebuilding operational foundations and preparing for 2026 innovation, with a…

    Read More “Back to Starbucks” strategy driving store growth amid margin pressure in the last quarterContinue

  • UnitedHealth Group presented rebuilding performance amid elevated medical cost trends in Q2 2025
    Market & Company News

    UnitedHealth Group presented rebuilding performance amid elevated medical cost trends in Q2 2025

    ByInvestment Club August 4, 2025August 4, 2025

    Overview UnitedHealth Group reported Q2 2025 results reflecting strong top-line growth but significant margin pressure from higher-than-anticipated medical costs. The company re-established its full-year 2025 outlook, incorporating revised expectations for medical cost trends and Medicare funding impacts. CEO Stephen Hemsley emphasized the company’s focus on restoring operating discipline and preparing for earnings recovery in 2026:…

    Read More UnitedHealth Group presented rebuilding performance amid elevated medical cost trends in Q2 2025Continue

  • AbbVie reports strong Q2 2025 results with Solid Immunology and Neuroscience growth
    Market & Company News

    AbbVie reports strong Q2 2025 results with Solid Immunology and Neuroscience growth

    ByInvestment Club August 3, 2025August 3, 2025

    Overview AbbVie delivered strong operational performance in the second quarter of 2025, supported by double-digit growth in Immunology and Neuroscience. Net revenues increased to $15.42bn, reflecting portfolio expansion and continued demand for key growth products. CEO Richard Gonzalez emphasized that AbbVie’s diversified portfolio and advancing pipeline position the company for sustainable long-term growth despite ongoing…

    Read More AbbVie reports strong Q2 2025 results with Solid Immunology and Neuroscience growthContinue

  • Chevron reports Q2 2025 results with strong cash flow and record production
    Market & Company News

    Chevron reports Q2 2025 results with strong cash flow and record production

    ByInvestment Club August 3, 2025August 3, 2025

    Overview Chevron delivered solid operational performance in the second quarter of 2025, supported by record oil-equivalent production and strong cash generation despite softer commodity pricing. The company continued to execute on its capital allocation strategy, returning significant cash to shareholders through dividends and buybacks, while integrating the recently completed Hess acquisition and expanding its energy…

    Read More Chevron reports Q2 2025 results with strong cash flow and record productionContinue

  • Lower commodity prices offset by record upstream production and disciplined cost management for Exxon Mobil in Q2 2025
    Market & Company News

    Lower commodity prices offset by record upstream production and disciplined cost management for Exxon Mobil in Q2 2025

    ByInvestment Club August 3, 2025August 3, 2025

    Overview ExxonMobil reported strong operational results for the second quarter of 2025, delivering solid cash flow and record upstream production despite lower crude and natural gas realizations. Net income for the quarter was $7.1bn, or $1.64 per diluted share, while free cash flow reached $5.4 bn. The company returned $9.2bn to shareholders through dividends and…

    Read More Lower commodity prices offset by record upstream production and disciplined cost management for Exxon Mobil in Q2 2025Continue

  • AWS, Advertising and International Expansion drive growth for Amazon in Q2 2025
    Market & Company News

    AWS, Advertising and International Expansion drive growth for Amazon in Q2 2025

    ByInvestment Club August 3, 2025August 3, 2025

    Overview Amazon delivered strong Q2 2025 results, supported by double-digit revenue growth across AWS, International, and Advertising. Operational efficiency and AI-driven innovation fueled significant improvements in operating income and net earnings. CEO Andy Jassy emphasized the transformative role of AI across Amazon’s ecosystem, enhancing customer experience, operational productivity, and revenue opportunities: “Our conviction that AI…

    Read More AWS, Advertising and International Expansion drive growth for Amazon in Q2 2025Continue

Page navigation

Previous PagePrevious 1 … 3 4 5 6 7 … 25 Next PageNext
  • Home
  • Events
  • Market & Company News
  • About
  • Members
  • Contact
Facebook Linkedin

Copyright © 2024 FSEGA Investment Club

  • Home
  • Events
  • Market & Company News
  • About
  • Members
  • Contact